Noven To Present At Roth 21st Annual Growth Stock Conference

-- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that it is scheduled to present an update on its business and prospects at the Roth 21st Annual OC Growth Stock Conference in California on Tuesday, February 17th at 11:00 a.m. PST (2:00 p.m. EST). The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter for at least two weeks at the same site.

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven’s business and operations are focused in three principal areas – transdermal drug delivery, the Novogyne joint venture, and Noven Therapeutics, Noven’s specialty pharmaceutical unit. For more information about Noven Pharmaceuticals, visit www.noven.com.

Contact:
Alina Bowman
Investor Relations Coordinator
305-253-1916